When Are Introns Removed During RNA Splicing?

The fundamental instructions for building and operating a cell are stored within the DNA. When a cell needs a specific product, the information is copied from the DNA into a temporary message molecule known as RNA. This flow of information, from DNA to RNA to protein, is a universally conserved mechanism directing all biological life. Proteins are the cell’s functional units, carrying out diverse tasks such as catalyzing reactions or providing structural support.

Defining Introns and Exons

The initial RNA copy of a gene, called the precursor messenger RNA (pre-mRNA), contains segments that do not contribute to the final protein sequence. These non-coding sections are known as introns, which intervene between the coding regions of the gene. Introns are often very long and vary greatly in size, sometimes spanning thousands of base pairs within the pre-mRNA transcript.

The sections of the gene that contain the instructions for the protein are called exons. Exons are the pieces that will ultimately be joined together to form the complete, functional message. In the human genome, a typical gene contains an average of 7 to 8 introns and 8 to 9 exons. The presence of these interspersed sequences means the raw RNA transcript must undergo modification before it is ready to be used as a template for protein production.

Timing and Location of RNA Splicing

RNA splicing, the removal of introns and the joining of exons, takes place exclusively within the nucleus. This controlled event occurs before the messenger RNA (mRNA) transcript can exit the nucleus and be translated into protein in the cytoplasm. This separation ensures that only fully processed and accurate genetic messages are used for protein synthesis.

Introns are removed not just after transcription is complete, but often while the gene is still actively being copied by the enzyme RNA polymerase II. This synchronized process is known as co-transcriptional splicing. The splicing machinery begins its work on the pre-mRNA even as the tail end is still being synthesized, which is highly efficient for organisms with long genes and introns. The result is the mature mRNA, a continuous sequence of exons ready to guide protein synthesis.

The Role of the Spliceosome Machinery

The precise excision of introns is performed by the spliceosome, a molecular complex. This machine is composed of five specialized small nuclear ribonucleoproteins (snRNPs), designated U1, U2, U4, U5, and U6. These snRNPs associate with additional protein factors, forming a dynamic complex nearly the size of a ribosome. The spliceosome is responsible for locating the exact boundaries between the introns and the exons, requiring nucleotide-level accuracy.

The process initiates when the U1 snRNP recognizes the 5’ splice site at the beginning of the intron. Simultaneously, the U2 snRNP binds to a conserved internal sequence called the branch point. This recognition is stabilized by the subsequent recruitment of the U4/U6 and U5 snRNPs, which assemble the full, active spliceosome complex. The chemical reaction proceeds in two steps, first involving a cut at the 5’ splice site, causing the intron to loop back on itself to form a lasso-like structure called a lariat.

The second step involves a cut at the 3’ splice site, releasing the intron lariat and simultaneously joining the two flanking exons together. The conserved sequences at the intron boundaries, typically beginning with the dinucleotide GU and ending with AG, serve as recognition signals for the snRNPs. Following the joining of the exons, the spliceosome disassembles, and the released intron lariat is degraded.

Alternative Splicing and Protein Diversity

The architecture of genes containing both introns and exons provides a biological advantage. This structure allows for alternative splicing, the cell’s ability to selectively include or exclude certain exons from the final mature mRNA transcript. A single gene sequence can therefore be processed in multiple ways, leading to the creation of several distinct mRNA molecules.

Each distinct mRNA variant, or isoform, created through alternative splicing can be translated into a structurally different protein. This permits a single gene to encode for a family of related proteins with unique functions or locations. For example, a protein involved in muscle contraction might have one isoform produced in skeletal muscle and a different isoform produced in heart muscle, optimizing its function for that specific tissue.

This flexibility is evident in complex systems like the human immune system, where a limited number of genes must generate a vast repertoire of different receptor proteins. Alternative splicing is the primary mechanism that allows this functional diversity. It is estimated that over 90% of human genes containing multiple exons are subject to this process, underscoring its importance in maximizing the complexity of the human proteome.